Objective The purpose of this study was to investigate the effect of disease modifying
therapies on immune response to severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2…

The general paradigm is that monocytes are recruited to sites of inflammation and terminally
differentiate into macrophages. There has been no demonstration of proliferation of …

T cells specific for SARS-CoV-2 are thought to protect against infection and development of
COVID-19, but direct evidence for this is lacking. Here, we associated whole-blood-based …

Background The relationship between intestinal epithelial integrity and the development of
intestinal disease is of increasing interest. A reduction in mucosal integrity has been …

5-Lipoxygenase (5-LOX) plays key roles in infection and allergic responses. Herein, four 5-LOX–derived
lipids comprising 5-hydroxyeicosatetraenoic acid (HETE) attached to …

Background People with MS treated with anti-CD20 therapies and fingolimod often have
attenuated responses to initial COVID-19 vaccination. However, uncertainties remain about the …

CD4 + T cells support host defence against herpesviruses and other viral pathogens. We
identified that CD4 + T cells from systemic and mucosal tissues of hosts infected with the β-…

Accurate assessment of SARS‐CoV‐2 immunity is critical in evaluating vaccine efficacy and
devising public health policies. Whilst the exact nature of effective immunity remains …

To the Editor Interventions to address viral persistence of COVID-19 in immunosuppressed
individuals are urgently needed for both patient and societal benefit [1]. Infection with the …

Current dogma suggests that tumor-reactive IFN-γ–producing (T H 1-type) T-cells are beneficial
to patient outcome; however, the clinical consequence of these responses with respect …